finn wrote:I hate to be a killjoy, but I believe that at the moment Goat Serum is very easy to discredit if one wishes to do so. So far there is no preclinical or clinical data about the drug, only anecdotal evidence.
But hopefully it will be as effective as the hype around it has made us hope it is, and also available sooner than thought.
markchip wrote:Regarding the cost of Aimspro...
At the moment the product is effectively "handmade" and therefore very expensive. However we (the patients and other investors) have been reliably told that costs of the serum in mass production will be VERY much cheaper indeed. One of Daval's aims is to be able to reach a very large proportion of those it can benefit and that will have to include the implications of cost. I believe that cost will therefore not be a major problem in the uptake of Aimspro. Beta interferon is without doubt rather expensive and, benefits aside, that factor in itself has been a problem for healthcare providers in the UK. It is anticipated that Aimspro will not face the same problems of high cost.
That said, we are not at that stage yet - Aimspro needs for the trial results to be published first and then a license to be granted.
Users browsing this forum: No registered users